Literature DB >> 6450804

Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production.

T A Fleisher, W C Greene, R M Blaese, T A Waldmann.   

Abstract

Human peripheral blood mononuclear cells (PBMC) activated with the mitogenic lectin concanavalin A (Con A) elaborate a soluble immune suppressor supernatant (SISS) that contains at least 2 distinct suppressor factors. One of these, SISS-B, inhibits polyclonal B cell immunoglobulin production whereas the other, SISS-T, suppresses T cell proliferation to both mitogens and antigens. The latter mediator is discussed in the companion paper. Characteristics of the human soluble suppressor of B cell immunoglobulin production (SISS-B) include: 1) inhibition by a noncytotoxic mechanism, 2) loss of activity in the presence of the monosaccharide L-rhamnose, 3) appearance within 8 to 16 hr after the addition of Con A, 4) elaboration by cells irradiated with 500 or 2000 rads, 5) production by highly purified T cells, 6) stability at pH 2.5 but instability at 56 degrees C, and 7) m.w. of 60 to 80,000. These data indicate that after Con A activation, selected T cells not only become potent suppressor cells, but also generate a soluble saccharide-specific factor(s) that inhibits polyclonal immunoglobulin production by human B cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450804

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Effect of in vitro colchicine and oral theophylline on suppressor cell function of asthmatic patients.

Authors:  D Ilfeld; S Kivity; E Feierman; M Topilsky; O Kuperman
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

2.  Suppression of in-vitro antibody production by pokeweed mitogen-stimulated human bone-marrow mononuclear cells. Evidence for a soluble suppressor substance.

Authors:  C D Alley; R P MacDermott; G S Nash; M J Bertovich
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

Review 3.  Human nonspecific suppressive lymphokines.

Authors:  M T Halpern
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

4.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

Authors:  J Laurence; A B Gottlieb; H G Kunkel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

5.  Characteristics of suppressor factors generated from human mononuclear cells using concanavalin A and C-reactive protein.

Authors:  A G Wangel; S Kontiainen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

6.  Hydrocortisone reverses the suppression of immunoglobulin synthesis by concanavalin A-activated spleen cell supernatants.

Authors:  D Ilfeld; R S Krakauer
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Purification and characterization of a mannose-containing disaccharide obtained from human pregnancy urine. A new immunoregulatory saccharide.

Authors:  A V Muchmore; J M Decker; R M Blaese; B Nilsson
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

8.  Reversal of infectious mononucleosis-associated suppressor T cell activity by D-mannose.

Authors:  G Tosato; S E Pike; R M Blaese
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

9.  A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.

Authors:  D Santoli; D J Tweardy; D Ferrero; B L Kreider; G Rovera
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.